NAF PLUS SOLUTION

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

SODIUM FLUORIDE F 18

可用日期:

ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.

ATC代码:

V09IX04

INN（国际名称）:

FLUDEOXYGLUCOSE (18F)

剂量:

7400MBq

药物剂型:

SOLUTION

组成:

SODIUM FLUORIDE F 18 7400MBq

给药途径:

INTRAVENOUS

每包单位数:

30ML

处方类型:

Schedule C

治疗领域:

ROENTGENOGRAPHY

產品總結:

Active ingredient group (AIG) number: 0153703002; AHFS:

授权状态:

APPROVED

授权日期:

2017-05-10

产品特点

PRODUCT MONOGRAPH
NaF Plus
Sodium Fluoride [
18
F] Injection, U.S.P.
Parenteral Solution
Diagnostic Radiopharmaceutical
Isologic Innovative Radiopharmaceuticals Ltd.
Date of Approval:
1855 32e Avenue, Lachine, Quebec H8T 3J1
Control # 171576
April 23, 2014
NaF Plus
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
................................................................................
3
DESCRIPTION
...........................................................................................................................
3
INDICATIONS AND CLINICAL USE
.....................................................................................
4
CONTRAINDICATIONS
...........................................................................................................
4
WARNINGS AND PRECAUTIONS
.........................................................................................
4
ADVERSE REACTIONS
...........................................................................................................
5
DRUG
INTERACTIONS............................................................................................................
5
DOSAGE AND ADMINISTRATION
.......................................................................................
6
RADIATION DOSIMETRY
......................................................................................................
7
OVERDOSAGE
..........................................................................................................................
7
ACTION AND CLINICAL PHARMACOLOGY
......................................................................
8
STORAGE AND STABILITY
...................................................................................................
8
SPECIAL HANDLING INSTRUCTIONS
.................................................................................
8
DOSAGE FORMS, COMPOSITION AND PACKAGING
..................................